Sadayappan V. Rahavendran

机构：Pfizer (United States)

发表论文 21 篇 · 总被引 629 次 · h-index 14

代表论文

• Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor (2009 · Journal of Medicinal Chemistry · 被引 119)
• Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase (2009 · Antimicrobial Agents and Chemotherapy · 被引 77)
• Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers (2010 · Investigational New Drugs · 被引 62)
• Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics (2010 · Investigational New Drugs · 被引 56)
• Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors (2009 · Journal of Medicinal Chemistry · 被引 53)
• Discovery Pharmacokinetic Studies in Mice Using Serial Microsampling, Dried Blood Spots And Microbore Lc–MS/MS (2012 · Bioanalysis · 被引 48)